Merck & Co., Inc. (VIE:MRK)

Austria flag Austria · Delayed Price · Currency is EUR
98.10
+2.90 (3.05%)
At close: Feb 3, 2026
2.51%
Market Cap243.38B +1.1%
Revenue (ttm)55.37B +1.3%
Net Income15.55B +6.6%
EPS6.20 +8.0%
Shares Outn/a
PE Ratio15.65
Forward PE22.38
Dividend2.86 (3.02%)
Ex-Dividend DateDec 15, 2025
Volume804
Average Volume117
Open95.70
Previous Close95.20
Day's Range94.70 - 99.70
52-Week Range66.10 - 98.10
Beta0.30
RSI68.96
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Vienna Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2025, Merck & Co.'s revenue was $65.01 billion, an increase of 1.31% compared to the previous year's $64.17 billion. Earnings were $18.25 billion, an increase of 6.64%.

Financial numbers in USD Financial Statements